Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Alta Bates Summit Medical Center
mi
from
Berkeley, CA
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Alta Bates Summit Medical Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
University of California, Davis Medical Center
mi
from
Sacramento, CA
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Multiple Sclerosis Center at UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Denver Neurological Research
mi
from
Denver, CO
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Denver Neurological Research
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Neurology Associates, PA
mi
from
Maitland, FL
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Neurology Associates, PA
mi
from
Maitland, FL
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Neurostudies, Inc.
mi
from
Port Charlotte, FL
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Neurostudies, Inc.
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Infinity Clinical Research, LLC
mi
from
Sunrise, FL
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
West Georgia Sleep Disorder Center and Neurology Associates
mi
from
Douglasville, GA
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
West Georgia Sleep Disorder Center and Neurology Associates
mi
from
Douglasville, GA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Washington University
mi
from
Saint Louis, MO
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
The Neurological Institute
mi
from
Charlotte, NC
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
The Neurological Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Neurology and Neuroscience Associates
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
The Polyclinic
mi
from
Seattle, WA
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
The Polyclinic
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated:  4/5/2018
Gomel Regional Clinical Hospital
mi
from
Gomel,
Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis (Radiance Study)
A Phase 2/3, Multi-center, Randomized, Double-blind, Placebo-controlled (Part A) and Double-blind, Double-dummy, Active-controlled (Part B), Parallel Group Study to Evaluate the Efficacy and Safety of RPC1063 Administered Orally to Relapsing Multiple Sclerosis Patients
Status: Enrolling
Updated: 4/5/2018
Gomel Regional Clinical Hospital
mi
from
Gomel,
Click here to add this to my saved trials
DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS
DESIPHER Speech Degradation as an Indicator of Physiological Degeneration in ALS
Status: Enrolling
Updated:  4/5/2018
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS
DESIPHER Speech Degradation as an Indicator of Physiological Degeneration in ALS
Status: Enrolling
Updated: 4/5/2018
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Status: Enrolling
Updated:  4/5/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis
Status: Enrolling
Updated: 4/5/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Mindfulness-based Stress Reduction for Multiple Sclerosis
Status: Enrolling
Updated:  4/6/2018
National College of Natural Medicine
mi
from
Portland, OR
Mindfulness-based Stress Reduction for Multiple Sclerosis
Status: Enrolling
Updated: 4/6/2018
National College of Natural Medicine
mi
from
Portland, OR
Click here to add this to my saved trials
The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration
The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration
Status: Enrolling
Updated:  4/8/2018
University of Utah
mi
from
Salt Lake City, UT
The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration
The Effect of Bariatric Surgery on Peripheral Nerve Function and Axonal Regeneration
Status: Enrolling
Updated: 4/8/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy
A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity
Status: Enrolling
Updated:  4/9/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy
A Multi-Center, Sham-Controlled, Double-Blind Randomized Withdrawal Study of PEMF Therapy to Evaluate Vibration Perception Threshold and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy in the Lower Extremity
Status: Enrolling
Updated: 4/9/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Transcranial Magnetic Stimulation in Stroke Motor Rehabilitation Treatment
Targeting Motor Areas for Customized Transcranial Magnetic Stimulation in Motor Rehabilitation Treatment of Chronic Stroke Patients
Status: Enrolling
Updated:  4/9/2018
Emory Hospital
mi
from
Atlanta, GA
Transcranial Magnetic Stimulation in Stroke Motor Rehabilitation Treatment
Targeting Motor Areas for Customized Transcranial Magnetic Stimulation in Motor Rehabilitation Treatment of Chronic Stroke Patients
Status: Enrolling
Updated: 4/9/2018
Emory Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Penumbra Imaging Collaborative Study (PICS)
Penumbra Imaging Collaborative Study (PICS): A Multicenter Trial to Assess Outcome of Patients Revascularized by the Penumbra™ System
Status: Enrolling
Updated:  4/10/2018
Swedish Medical Center
mi
from
Englewood, CO
Penumbra Imaging Collaborative Study (PICS)
Penumbra Imaging Collaborative Study (PICS): A Multicenter Trial to Assess Outcome of Patients Revascularized by the Penumbra™ System
Status: Enrolling
Updated: 4/10/2018
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Status: Enrolling
Updated:  4/10/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Status: Enrolling
Updated: 4/10/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Using OCT to Capture Retinal Microvascular Changes Associated With MS
Status: Enrolling
Updated:  4/10/2018
Oregon Health and Science University
mi
from
Portland, OR
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Using OCT to Capture Retinal Microvascular Changes Associated With MS
Status: Enrolling
Updated: 4/10/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated:  4/10/2018
Spectrum Neuroscience and Treatment Institute
mi
from
New York, NY
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated: 4/10/2018
Spectrum Neuroscience and Treatment Institute
mi
from
New York, NY
Click here to add this to my saved trials
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated:  4/10/2018
Institute of Neurology and Neurosurgery at St. Barnabas
mi
from
Livingston, NJ
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated: 4/10/2018
Institute of Neurology and Neurosurgery at St. Barnabas
mi
from
Livingston, NJ
Click here to add this to my saved trials
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/10/2018
Northwest Behavioral Research Center
mi
from
Marietta, GA
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/10/2018
Northwest Behavioral Research Center
mi
from
Marietta, GA
Click here to add this to my saved trials
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/10/2018
New York University School of Medicine
mi
from
New York, NY
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/10/2018
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/10/2018
The Medical Research Network, LLC
mi
from
New York, NY
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/10/2018
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  4/10/2018
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 4/10/2018
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures: A Model of Patient Engagement in Functional Neurological Symptom Disorders
Status: Enrolling
Updated:  4/10/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures: A Model of Patient Engagement in Functional Neurological Symptom Disorders
Status: Enrolling
Updated: 4/10/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.
Status: Enrolling
Updated:  4/10/2018
MidAmerica Neuroscience Institute
mi
from
Kansas City, MO
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.
Status: Enrolling
Updated: 4/10/2018
MidAmerica Neuroscience Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism
A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism
Status: Enrolling
Updated:  4/10/2018
Hearts and Horses Therapeutic Riding Center
mi
from
Loveland, CO
A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism
A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism
Status: Enrolling
Updated: 4/10/2018
Hearts and Horses Therapeutic Riding Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  4/11/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 4/11/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  4/11/2018
Columbia University Medical Center
mi
from
New York, NY
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 4/11/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  4/11/2018
University of Virginia
mi
from
Charlottesville, VA
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 4/11/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  4/11/2018
Northwestern University
mi
from
Chicago, IL
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 4/11/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  4/11/2018
Univ of Washington
mi
from
Seattle, WA
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 4/11/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Rasch-analysis of Clinical Severity in FSHD
Rasch-analysis of Clinical Severity in FSHD
Status: Enrolling
Updated:  4/11/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Rasch-analysis of Clinical Severity in FSHD
Rasch-analysis of Clinical Severity in FSHD
Status: Enrolling
Updated: 4/11/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Rasch-analysis of Clinical Severity in FSHD
Rasch-analysis of Clinical Severity in FSHD
Status: Enrolling
Updated:  4/11/2018
University of Utah
mi
from
Salt Lake City, UT
Rasch-analysis of Clinical Severity in FSHD
Rasch-analysis of Clinical Severity in FSHD
Status: Enrolling
Updated: 4/11/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Strength Training to Improve Gait in People With Multiple Sclerosis
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
Status: Enrolling
Updated:  4/11/2018
University of Colorado Denver
mi
from
Aurora, CO
Strength Training to Improve Gait in People With Multiple Sclerosis
Targeted Strength Training to Improve Gait in People With Multiple Sclerosis: a Feasibility Study
Status: Enrolling
Updated: 4/11/2018
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Lake Mary Pediatrics
mi
from
Orange City, FL
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Lake Mary Pediatrics
mi
from
Orange City, FL
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Institute for Behavioral Medicine
mi
from
Smyrna, GA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Ohio State University
mi
from
Columbus, OH
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Cyn3rgy Research
mi
from
Gresham, OR
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials